Connection

Richard Drake to Glycosylation

This is a "connection" page, showing publications Richard Drake has written about Glycosylation.
Connection Strength

2.562
  1. Applications and continued evolution of glycan imaging mass spectrometry. Mass Spectrom Rev. 2023 03; 42(2):674-705.
    View in: PubMed
    Score: 0.178
  2. Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain. J Neuroinflammation. 2021 May 16; 18(1):116.
    View in: PubMed
    Score: 0.175
  3. Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells. Clin Lab Med. 2021 06; 41(2):247-266.
    View in: PubMed
    Score: 0.174
  4. Optimization of Multiple Glycosidase and Chemical Stabilization Strategies for N-Glycan Isomer Detection by Mass Spectrometry Imaging in Formalin-Fixed, Paraffin-Embedded Tissues. Methods Mol Biol. 2021; 2271:303-316.
    View in: PubMed
    Score: 0.170
  5. Array-Based N-Glycan Profiling of Cells in Culture. Methods Mol Biol. 2021; 2271:331-342.
    View in: PubMed
    Score: 0.170
  6. Rapid N-Glycan Profiling of Serum and Plasma by a Novel Slide-Based Imaging Mass Spectrometry Workflow. J Am Soc Mass Spectrom. 2020 Dec 02; 31(12):2511-2520.
    View in: PubMed
    Score: 0.166
  7. Defining the human kidney N-glycome in normal and cancer tissues using MALDI imaging mass spectrometry. J Mass Spectrom. 2020 Apr; 55(4):e4490.
    View in: PubMed
    Score: 0.159
  8. Glycosylation and its implications in breast cancer. Expert Rev Proteomics. 2019 08; 16(8):665-680.
    View in: PubMed
    Score: 0.154
  9. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues. Adv Cancer Res. 2017; 134:85-116.
    View in: PubMed
    Score: 0.129
  10. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Biomolecules. 2015 Oct 15; 5(4):2554-72.
    View in: PubMed
    Score: 0.118
  11. Glycosylation and cancer: moving glycomics to the forefront. Adv Cancer Res. 2015; 126:1-10.
    View in: PubMed
    Score: 0.113
  12. Altered glycosylation in prostate cancer. Adv Cancer Res. 2015; 126:345-82.
    View in: PubMed
    Score: 0.113
  13. Unique to this volume is the subsequent focus of individual chapters on what is known about glycosylation in relation to specific organ sites of cancer. Preface. Adv Cancer Res. 2015; 126:xiii-xiv.
    View in: PubMed
    Score: 0.112
  14. Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Mol Cell Proteomics. 2022 05; 21(5):100225.
    View in: PubMed
    Score: 0.046
  15. GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis. Front Immunol. 2022; 13:797460.
    View in: PubMed
    Score: 0.046
  16. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes. Mol Cancer Res. 2021 11; 19(11):1868-1877.
    View in: PubMed
    Score: 0.044
  17. Brain glycogen serves as a critical glucosamine cache required for protein glycosylation. Cell Metab. 2021 07 06; 33(7):1404-1417.e9.
    View in: PubMed
    Score: 0.044
  18. Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced N-glycosylation Abundance and Branching. Cancer Res. 2021 05 15; 81(10):2625-2635.
    View in: PubMed
    Score: 0.043
  19. Spatial N-glycomics of the human aortic valve in development and pediatric endstage congenital aortic valve stenosis. J Mol Cell Cardiol. 2021 05; 154:6-20.
    View in: PubMed
    Score: 0.043
  20. Multiplexed Imaging Mass Spectrometry of Histological Staining, N-Glycan and Extracellular Matrix from One Tissue Section: A Tool for Fibrosis Research. Methods Mol Biol. 2021; 2350:313-329.
    View in: PubMed
    Score: 0.043
  21. New Enzymatic Approach to Distinguish Fucosylation Isomers of N-Linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry. J Proteome Res. 2020 08 07; 19(8):2989-2996.
    View in: PubMed
    Score: 0.041
  22. Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery. Curr Protoc Protein Sci. 2019 12; 98(1):e99.
    View in: PubMed
    Score: 0.039
  23. A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging. Anal Chem. 2019 07 02; 91(13):8429-8435.
    View in: PubMed
    Score: 0.038
  24. Core-Fucosylated Tetra-Antennary N-Glycan Containing A Single N-Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer. Int J Mol Sci. 2019 May 23; 20(10).
    View in: PubMed
    Score: 0.038
  25. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging. J Proteome Res. 2018 10 05; 17(10):3454-3462.
    View in: PubMed
    Score: 0.036
  26. Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing. Anal Chem. 2016 12 06; 88(23):11584-11592.
    View in: PubMed
    Score: 0.032
  27. Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer. Oncotarget. 2015 Dec 22; 6(41):43743-58.
    View in: PubMed
    Score: 0.030
  28. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics. 2013 Oct; 12(10):2935-51.
    View in: PubMed
    Score: 0.025
  29. Application of an N-(4-azido-2,3,5,6-tetrafluorobenzoyl)tyrosine-substituted peptide as a heterobifunctional cross-linking agent in a study of protein O-glycosylation in yeast. Bioconjug Chem. 1992 Jan-Feb; 3(1):69-73.
    View in: PubMed
    Score: 0.023
  30. Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics. 2004 Mar; 4(3):826-38.
    View in: PubMed
    Score: 0.013
  31. Inhibition of glycosylation by amphomycin and sugar nucleotide analogs PP36 and PP55 indicates that Haloferax volcanii beta-glucosylates both glycoproteins and glycolipids through lipid-linked sugar intermediates: evidence for three novel glycoproteins and a novel sulfated dihexosyl-archaeol glycolipid. Arch Biochem Biophys. 1995 Jun 01; 319(2):355-64.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.